The Authors’ Reply.
- Published in:
- Drug Safety, 2005, v. 28, n. 8, p. 742
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2005 AND VI 28 AND IP 8
Results: 9
1
2
Tolerability of Treatments for Postherpetic Neuralgia.
- Published in:
- Drug Safety, 2005, v. 28, n. 8, p. 741, doi. 10.2165/00002018-200528080-00008
- By:
- Publication type:
- Article
3
Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
- Published in:
- 2005
- By:
- Publication type:
- journal article
4
Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
- Published in:
- 2005
- By:
- Publication type:
- journal article
5
Fetal Safety of Drugs Used in the Treatment of Allergic Rhinitis: A Critical Review.
- Published in:
- Drug Safety, 2005, v. 28, n. 8, p. 707, doi. 10.2165/00002018-200528080-00005
- By:
- Publication type:
- Article
6
Treating mood disorders during pregnancy: safety considerations.
- Published in:
- 2005
- By:
- Publication type:
- journal article
7
Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.
- Published in:
- 2005
- By:
- Publication type:
- journal article
8
The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.
- Published in:
- 2005
- By:
- Publication type:
- journal article
9
What are the real lessons from Vioxx?
- Published in:
- 2005
- By:
- Publication type:
- Editorial